secwatch.observer — SEC 8-K summary
======================================

Issuer:     vTv Therapeutics Inc. (VTVT)
CIK:        0001641489
Form:       8-K
Filed at:   2024-03-26T23:59:59+00:00
Accession:  0001641489-24-000020
Event type: regulatory
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

vTv Therapeutics regains Nasdaq MVLS compliance; listing continues
------------------------------------------------------------------

- Nasdaq notified vTv Therapeutics on March 25, 2024 that it regained compliance with the $35M MVLS minimum.
- Common stock ticker VTVT will continue listing on the Nasdaq Capital Market.
- No further deficiency actions required; prior MVLS concern resolved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641489/000164148924000020/0001641489-24-000020-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641489/000164148924000020/vtvt-20240325.htm
  HTML page:      https://secwatch.observer/filing/0001641489-24-000020

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer